ATWOOD & PALMER INC - MANNKIND CORP ownership

MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 126 filers reported holding MANNKIND CORP in Q2 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
ATWOOD & PALMER INC ownership history of MANNKIND CORP
ValueSharesWeighting
Q2 2024$10,440
+15.2%
2,0000.0%0.00%0.0%
Q1 2024$9,060
+24.5%
2,0000.0%0.00%0.0%
Q4 2023$7,280
-11.9%
2,0000.0%0.00%0.0%
Q3 2023$8,260
+1.5%
2,0000.0%0.00%0.0%
Q2 2023$8,140
-0.7%
2,0000.0%0.00%0.0%
Q1 2023$8,200
-22.2%
2,0000.0%0.00%0.0%
Q4 2022$10,540
+75.7%
2,0000.0%0.00%0.0%
Q3 2022$6,000
-25.0%
2,0000.0%0.00%0.0%
Q2 2022$8,000
+14.3%
2,0000.0%0.00%0.0%
Q1 2022$7,000
-22.2%
2,0000.0%0.00%0.0%
Q4 2021$9,0000.0%2,0000.0%0.00%0.0%
Q3 2021$9,000
-18.2%
2,0000.0%0.00%0.0%
Q2 2021$11,000
+37.5%
2,0000.0%0.00%0.0%
Q1 2021$8,000
+33.3%
2,0000.0%0.00%0.0%
Q4 2020$6,000
+20.0%
2,000
-28.6%
0.00%0.0%
Q3 2020$5,0000.0%2,8000.0%0.00%0.0%
Q2 2020$5,000
+66.7%
2,8000.0%0.00%
Q1 2020$3,000
-25.0%
2,8000.0%0.00%
-100.0%
Q4 2019$4,0000.0%2,8000.0%0.00%0.0%
Q3 2019$4,000
+33.3%
2,8000.0%0.00%
Q2 2019$3,000
-50.0%
2,8000.0%0.00%
-100.0%
Q1 2019$6,000
+100.0%
2,8000.0%0.00%
Q4 2018$3,000
-40.0%
2,8000.0%0.00%
-100.0%
Q3 2018$5,000
+150.0%
2,800
+250.0%
0.00%
Q2 2018$2,0000.0%8000.0%0.00%
Q1 2018$2,0000.0%8000.0%0.00%
Q4 2017$2,0000.0%8000.0%0.00%
Q3 2017$2,000
+100.0%
8000.0%0.00%
Q2 2017$1,0000.0%8000.0%0.00%
Q1 2017$1,0008000.00%
Other shareholders
MANNKIND CORP shareholders Q2 2018
NameSharesValueWeighting ↓
180 WEALTH ADVISORS, LLC 1,485,335$4,590,0001.26%
1492 Capital Management LLC 546,710$1,689,0001.22%
Parkman Healthcare Partners LLC 924,979$2,858,0000.81%
EMERALD ADVISERS, LLC 3,765,284$11,635,0000.60%
Avoro Capital Advisors LLC 9,100,000$28,119,0000.52%
Telemetry Investments, L.L.C. 90,000$278,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 1,775,609$5,487,0000.35%
SCOPIA CAPITAL MANAGEMENT LP 694,961$2,147,0000.20%
Bruce & Co., Inc. 195,073$602,0000.16%
DUPONT CAPITAL MANAGEMENT CORP 726,200$2,244,0000.13%
View complete list of MANNKIND CORP shareholders